Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

ClinicalTrials.gov ID: NCT00040846

Public ClinicalTrials.gov record NCT00040846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Campath® [Alemtuzumab] Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class I Mismatched Donor Stem Cell Transplantation for Patients With Hematologic Malignancies - A Multi-Center Trial

Study identification

NCT ID: NCT00040846
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Fred Hutchinson Cancer Center; Other
Enrollment: 60 participants

Conditions and interventions

Conditions

Interventions

alemtuzumab Biological
allogeneic hematopoietic stem cell transplantation Procedure
cyclosporine Drug
fludarabine phosphate Drug
mycophenolate mofetil Drug
peripheral blood stem cell transplantation Procedure
total-body irradiation Radiation

Biological · Procedure · Drug + 1 more

Eligibility (public fields only)

Age range: Up to 74 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2001
Primary completion: Nov 30, 2009
Completion: Nov 30, 2009
Last update posted: Jan 28, 2020

2001 – 2009

United States locations

U.S. sites: 6
U.S. states: 4
U.S. cities: 4

Facility	City	State	ZIP	Site status
Presbyterian - Saint Lukes Medical Center - Health One	Denver	Colorado	80218	—
Huntsman Cancer Institute/University of Utah	Salt Lake City	Utah	84112	—
LDS Hospital	Salt Lake City	Utah	84143	—
VA Puget Sound Health Care System	Seattle	Washington	98101	—
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Seattle	Washington	98109	—
Froedtert Memorial Lutheran Hospital, Medical College of Wisconsin	Milwaukee	Wisconsin	53226	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00040846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 28, 2020 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00040846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →